Abstract
Background
Iron deficiency and hepatic steatosis are common in bariatric surgery patients. Steatosis can falsely elevate ferritin values even in presence of iron deficiency. This study aims to assess the influence of hepatic steatosis on iron deficiency and replacement therapy after bariatric surgery.
Methods
Seventy-nine individuals undergoing gastric bypass have been studied at 4 time points (preoperative and 1, 3, and 6 months after surgery). Weight, body mass index (BMI), iron, ferritin, vitamin B12, folate, hemoglobin, gamma-glutamyl transferase (GGT), alanine aminotransferase (ALT), aspartate aminotransferase (AST), and use of iron replacement were recorded.
Results
Forty-two individuals (53%) had moderate/severe steatosis assessed by ultrasound. No differences were seen in iron profile and replacement therapy features compared to individuals with no/mild steatosis both in the preoperative and postoperative periods. Mixed model analysis showed ferritin levels to be higher in the moderate/severe steatosis group than in no/mild steatosis at the 6th month (139 ± 131 vs. 60.9 ± 49.8, p < 0.05). Values in both groups were lower than baseline, with p < 0.0001. The same was observed with serum iron (92.1 ± 39.6 moderate/severe steatosis vs. 68.6 ± 33.4 no/mild steatosis, p < 0.001; p from baseline < 0.01 for both). GGT was higher in moderate/severe steatosis in the 3rd month (38.8 ± 40.5 vs. 28.8 ± 20.8, p < 0.05; p from baseline < 0.0001 for both).
Conclusions
Ferritin levels were consistently higher in individuals with steatosis in the follow-up of bariatric surgery, but no apparent implication on the diagnosis of iron deficiency and in the prescription of replacement therapy was demonstrated at 6 months of follow-up. Longer studies are probably necessary to investigate this matter.
Graphical abstract
Similar content being viewed by others
References
Blüher M. Obesity: global epidemiology and pathogenesis. Nat Rev Endocrinol. 2019;15:288–98.
Tremmel M, Gerdtham U-G, Nilsson PM, Saha S. Economic burden of obesity: a systematic literature review. Int J Environ Res Pu. 2017;14:435.
O’Brien PE, Hindle A, Brennan L, Skinner S, Burton P, Smith A, et al. Long-term outcomes after bariatric surgery: a systematic review and meta-analysis of weight loss at 10 or more years for all bariatric procedures and a single-centre review of 20-year outcomes after adjustable gastric banding. Obes Surg. 2019;29:3–14.
Young MT, Gebhart A, Phelan MJ, Nguyen NT. Use and outcomes of laparoscopic sleeve gastrectomy vs laparoscopic gastric bypass: analysis of the American College of Surgeons NSQIP. J Am Coll Surgeons. 2015;220:880–5.
Borisenko O, Colpan Z, Dillemans B, Funch-Jensen P, Hedenbro J, Ahmed AR. Clinical indications, utilization, and funding of bariatric surgery in Europe. Obes Surg. 2015;25:1408–16.
Bal BS, Finelli FC, Shope TR, Koch TR. Nutritional deficiencies after bariatric surgery. Nat Rev Endocrinol. 2012;8:544–56.
Barr J, Caballería J, Martínez-Arranz I, Domínguez-Díez A, Alonso C, Muntané J, et al. Obesity-dependent metabolic signatures associated with nonalcoholic fatty liver disease progression. J Proteome Res. 2012;11:2521–32.
Pontiroli AE, Benetti A, Folini L, Merlotti C, Frigè F. Other aspects of bariatric surgery: liver steatosis, ferritin and cholesterol metabolism. Nutr Hosp. 2013;28(Suppl 2):104–8.
Kheniser KG, Kashyap SR, Schauer PR, Lam ETC, Kullman ES. Prevalence of anemia in subjects randomized into roux-en-Y gastric bypass or sleeve gastrectomy. Obes Surg. 2017;27:1381–6.
Kowdley KV, Belt P, Wilson LA, Yeh MM, Neuschwander-Tetri BA, Chalasani N, et al. Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease. Hepatology. 2012;55:77–85.
Jung JY, Shim J-J, Park SK, Ryoo J-H, Choi J-M, Oh I-H, et al. Serum ferritin level is associated with liver steatosis and fibrosis in Korean general population. Hepatol Int. 2019;13:222–33.
Krzizek E-C, Brix JM, Stöckl A, Parzer V, Ludvik B. Prevalence of Micronutrient Deficiency after Bariatric Surgery. Obes Facts. 2021;14:197–204.
Steenackers N, der Schueren BV, Mertens A, Lannoo M, Grauwet T, Augustijns P, et al. Iron deficiency after bariatric surgery: what is the real problem? P Nutr Soc. 2018;77:445–55.
Lewis C-A, de Jersey S, Seymour M, Hopkins G, Hickman I, Osland E. Iron, vitamin B12, folate and copper deficiency after bariatric surgery and the impact on anaemia: a systematic review. Obes Surg. 2020;30:4542–91.
Andrews NC. Forging a field: the golden age of iron biology. Blood. 2008;112:219–30.
Lynch S, Pfeiffer CM, Georgieff MK, Brittenham G, Fairweather-Tait S, Hurrell RF, et al. Biomarkers of nutrition for development (BOND)—iron review. J Nutrition. 2018;148:1001S-1067S.
Shankar P, Boylan M, Sriram K. Micronutrient deficiencies after bariatric surgery. Nutrition. 2010;26:1031–7.
Malinowski SS. Nutritional and metabolic complications of bariatric surgery. Am J Medical Sci. 2006;331:219–25.
Antoine D, Li Z, Quilliot D, Sirveaux M-A, Meyre D, Mangeon A, et al. Medium term post-bariatric surgery deficit of vitamin B12 is predicted by deficit at time of surgery. Clin Nutr. 2021;40:87–93.
Li Z, Gueant-Rodriguez R-M, Quilliot D, Sirveaux M-A, Meyre D, Gueant J-L, et al. Folate and vitamin B12 status is associated with insulin resistance and metabolic syndrome in morbid obesity. Clin Nutr. 2018;37:1700–6.
Guan B, Chen Y, Chong TH, Peng J, Mak TK, Wang C, et al. Effect of bariatric surgery on serum enzyme status in obese patients. Obes Surg. 2020;30:2700–7.
Burza MA, Romeo S, Kotronen A, Svensson P-A, Sjöholm K, Torgerson JS, et al. Long-term effect of bariatric surgery on liver enzymes in the Swedish Obese Subjects (SOS) study. Plos One. 2013;8:e60495.
Ledoux S, Sami O, Calabrese D, Gall ML, Flamant M, Coupaye M. Gastric bypass specifically impairs liver parameters as compared with sleeve gastrectomy, independently of evolution of metabolic disorders. Surg Obes Relat Dis. 2019;15:220–6.
Lassailly G, Caiazzo R, Ntandja-Wandji L-C, Gnemmi V, Baud G, Verkindt H, et al. Bariatric surgery provides long-term resolution of nonalcoholic steatohepatitis and regression of fibrosis. Gastroenterology. 2020;159:1290-1301.e5.
Wu J, You J, Yerian L, Shiba A, Schauer PR, Sessler DI. Prevalence of liver steatosis and fibrosis and the diagnostic accuracy of ultrasound in bariatric surgery patients. Obes Surg. 2012;22:240–7.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Statement of Informed Consent
Since this is a retrospective study of medical records, no formal consent was required.
Conflict of Interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Key Points
• Iron deficiency is a common complication after Roux-en-Y gastric bypass (RYGB), but hepatic steatosis can falsely elevate ferritin levels.
• Ferritin levels were lower after RYGB, but significantly higher in individuals with established steatosis.
• Mild anemia was seen in all individuals postoperatively, but no interaction with steatosis was demonstrated.
• No apparent implication of this finding was seen in the prescription of iron replacement therapy.
Rights and permissions
About this article
Cite this article
da Costa Leite Junior, G., Lacerda, M.D., Alencar, T.A.L.B. et al. Behavior of Iron and Ferritin After Bariatric Surgery in Patients With and Without Hepatic Steatosis. OBES SURG 31, 4761–4766 (2021). https://doi.org/10.1007/s11695-021-05629-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11695-021-05629-x